Damodar Kumbala is a Nephrology physician affiliated with Baton Rouge Clinic. OpenAlex indexes 24 publications with 504 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5131 Odonovan Dr Ste 100
Baton Rouge, LA 708084791
Telephone
225-767-4893Provider last certified this registry record 29 Jun 2022.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Otsuka America Pharmaceutical, Inc.Program year20256 payments
- Mallinckrodt Hospital Products Inc.Program year20254 payments
- Fresenius USA Marketing, Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
53%Angiotensin receptor blocker (ARB)10.8%Losartan Potassium100%Part D≥47 patientsLoop diuretic9.1%Furosemide100%Part D≥40 patients+ 10 more classes in this area
Metabolism & gastrointestinal
35%SGLT2 inhibitor16%Farxiga68%Jardiance32%Part D≥41 patientsVitamin D3 Analog13.4%Rayaldee100%Part D≥31 patients+ 3 more classes in this area
Other
8.3%Drugs for treatment of hyperkalemia and hyperphosphatemia6.2%Lokelma47%Auryxia30%Velphoro23%Part D<11 patientsPhosphate Binder2.1%Sevelamer Carbonate100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Device-based therapies in cardio-renal syndrome: a pathophysiology-driven approach to a complex bidirectional disease
Frontiers in Cardiovascular Medicine
2026 - A case report of mediastinal parathyroid carcinoma in a chronic kidney disease patient: Addressing management conundrum
SAGE Open Medical Case Reports
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”